4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-140856
President and CEO sold 8,400 shares at $11.87 ($99,708)
From the SEC's structured data for this filing
Trades in this filing
AHMED NADIM · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-24 | Sale : show line 1 in the form | −8,400 | $11.87 | $99,708 | 263,150 | D |
| Open-market sales · 8,400 sh · avg $11.87 · $99,708 | ||||||
Loading xslF345X05/ownership.xml…